Skip to content

DR. VERA ZIMMERMANN

Active
Private limited companyfounded 2015active for 11 yearsGrachtstrasse 38, 4730 Raeren, BelgiumKBO/BCE: BE 0631.964.502
Summary

DR. VERA ZIMMERMANN has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,460 and a net result of €106,821. Equity has been shrinking by about 22% per year since 2018. The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 12-06-2015 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.243.553.679 4730 Raeren, since 15-07-2015
Financial year end
31 December
Peppol
Reachable since 16-12-2025

Board and ownership

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€152,202
▲ 20.3%
Turnover
≈ €280,000
estimated
Profit
€106,821
▲ 17.6%
Equity
€20,460
▼ 77.4%
Total assets
€187,868
▼ 37.7%
Filed on 10-04-2026, 112 days before the deadline
Score breakdownraises riskEquity €20,460 (10.9% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €187,868Liquidity: current ratio 0.87, cash €86,246, halvedShow the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 31% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 36-19
equity 10.9% of total assets
Liquidity 51-12
short-term debt 89.1% · cash 45.9%
Profitability 100=
return on assets 56.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.87 (1.17 in 2024), below 1. Short-term debt is 89.1% and cash 45.9% of total assets. 89.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 15% of them on solvency, 23% on liquidity, 80% on profitability and 8% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €187,868
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €20,460 (10.9% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.87, cash €86,246, halved
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-04-2026, 112 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
112 days early
2024
121 days early
2023
43 days early
2022
47 days early
2021
44 days early
2020
115 days early
2019
49 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 76 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 June (4 of the last 5 accounts filed within 65 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €90,548 to €20,460 ▼ 77.4% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €106,821 8 years View

Recent changes

  1. · Gazette deed Appointment: ZIMMERMANN Vera Josephine (nicht statutäre verwalterin)
  2. · Gazette deed Incorporation
All 17 events

Comparable companies

These companies have the same main activity as DR. VERA ZIMMERMANN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €173,000 and €213,000, founded between 2014 and 2016.

CompanyTotal assetsGross margin
DR. VERA ZIMMERMANN Raeren€187,868€152,202
PsyPluriel-Liège Liège€182,097€147,911
Oscar Medis Nivelles€212,550€154,754
SFJ VAN EECKHOUDT Kalmthout€173,040€165,948
OLIVIER CLARINVAL ANESTHESIE Libramont-Chevigny€212,721€162,634
DR. KLARA VAN GOOL,NEUS-, KEEL-EN OORSPECIALIST Kalmthout€191,131€134,761
DR CHOUCHANE Ganshoren€212,603€166,187
Full comparison

Key facts about DR. VERA ZIMMERMANN

What is the company number of DR. VERA ZIMMERMANN?
The company number of DR. VERA ZIMMERMANN is 0631.964.502. The VAT number is the same number with BE in front: BE 0631.964.502.
Where is DR. VERA ZIMMERMANN based?
The registered office is at Grachtstrasse 38, 4730 Raeren.Company details
What does DR. VERA ZIMMERMANN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. VERA ZIMMERMANN?
The legal form of DR. VERA ZIMMERMANN is Private limited company (BV).
When was DR. VERA ZIMMERMANN founded?
DR. VERA ZIMMERMANN was founded on 12-06-2015.
Is DR. VERA ZIMMERMANN still active?
Yes, DR. VERA ZIMMERMANN is an active enterprise in the KBO register.
What is the turnover of DR. VERA ZIMMERMANN?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €152,202 and 43 comparable companies (NACE 86220). It probably lies between €240,000 and €380,000.Financials
Is DR. VERA ZIMMERMANN profitable?
In financial year 2025, DR. VERA ZIMMERMANN made a profit of €106,821.
Where can I find the annual accounts of DR. VERA ZIMMERMANN?
DR. VERA ZIMMERMANN filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. VERA ZIMMERMANN due?
DR. VERA ZIMMERMANN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.